Public, NASDAQ:EMIS
NASDAQ Global Market
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
Date: Thu, 03 Jul 2008 14:10:20 GMT
Tags:
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
Cancer Focus - Jul 3, 2008
Cancer Focus - Jul 3, 2008
Emisphere Technologies , Inc . ( NASDAQ : EMIS ) announced today that Novartis Pharma AG has launched a Phase I study in postmenopausal women to determine the safety and tolerability of oral ...
Emisphere Technologies Announces The Launch Of A Human Clinical Trial For Oral Parathyroid Hormone (PTH)
Date: Tue, 01 Jul 2008 08:13:15 GMT
Tags:
Emisphere Technologies Announces The Launch Of A Human Clinical Trial For Oral Parathyroid Hormone (PTH)
Medical News Today (press release) - Jul 1, 2008
Medical News Today (press release) - Jul 1, 2008
Emisphere Technologies , Inc . ( Nasdaq : EMIS ) announced that Novartis Pharma AG has launched a Phase I study in postmenopausal women to determine the safety and tolerability of oral PTH134 ...
WallStreetGrapevine.com: Stocks on the Rise: NILR, EMIS, SYMW
Date: Mon, 30 Jun 2008 14:47:42 GMT
Tags:
WallStreetGrapevine.com: Stocks on the Rise: NILR, EMIS, SYMW
Trading Markets (press release) - Jun 30, 2008
Trading Markets (press release) - Jun 30, 2008
Jun 30 , 2008 ( M2 PRESSWIRE via COMTEX ) - - SYMW | Quote | Chart | News | PowerRating - - Wall Street , NYC - Today , wallstreetgrapevine . com has named ; Nilam Resources Inc . ( OTC BB : ...
Novartis using Emisphere technology in tests
Date: Mon, 30 Jun 2008 14:32:12 GMT
Tags:
Novartis using Emisphere technology in tests
Business in the Burbs - Jun 30, 2008
Business in the Burbs - Jun 30, 2008
Emisphere Technologies Inc . , the biopharmaceutical company with research and development operations in Eastview , said this morning that Novartis Pharma AG has launched a study to determine ...
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
Date: Mon, 30 Jun 2008 13:24:16 GMT
Tags:
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
PR Newswire (press release) - Jun 30, 2008
PR Newswire (press release) - Jun 30, 2008
Phase I Study to Explore the Effects of Eligen ( R ) Delivery Technology on Healthy Postmenopausal Women CEDAR KNOLLS , NJ , June 30 / PRNewswire - FirstCall / - - Emisphere Technologies , Inc ...
Profit Locally, Invest Globally (at Investopedia)
Date: Mon, 30 Jun 2008 18:37:47 Etc/GMT
Tags:
Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH) (PR Newswire)
Date: Mon, 30 Jun 2008 12:50:00 Etc/GMT
Tags:
Emisphere Technologies, Inc. announced today that Novartis Pharma AG has launched a Phase I study in postmenopausal women to determine the safety and tolerability of oral PTH134, a combination of human PTH-1-34 and the absorption enhancer 5-CNAC using Emisphere's proprietary Eligen® technology, for the treatment of postmenopausal osteoporosis.
A Diabetes Drug Delivery Deal (at Motley Fool)
Date: Tue, 24 Jun 2008 19:37:46 Etc/GMT
Tags:
Emisphere shares jump on Novo Nordisk deal (AP)
Date: Mon, 23 Jun 2008 17:13:24 Etc/GMT
Tags:
Shares of Emisphere Technologies Inc. rose Monday after the company said it signed a licensing deal worth at least $87 million with Novo Nordisk to develop diabetes treatments.
EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)
Date: Mon, 23 Jun 2008 13:15:03 Etc/GMT
Tags: